AKT1 and prostate carcinoma: These data suggest that BP suppresses prostate cancer cells proliferation via cell cycle arrest by regulating the cyclin/CDK/CKI cell cycle regulatory protein and targeting the Akt-GSK-3β-Cyclin D1 signaling axis.